Attana to present at GDDIF 2018, Global Discovery to Development Innovtion Forum, in Amsterdam May 16-17, 2018
The Global Discovery to Development Innovation Forum is a leading pharmaceutical R&D Summit for pharma decision makers, scientific leaders, and solutions experts. Attana will attend the conference both as a speaker and exhibiting our technology. The presentation, Passion for interactions with cells: From molecule to drug!, is given by Attana´s CEO Dr.Teodor Aastrup. http://www.gddif.com/speakers2018.html
The GDDIF conference bring together leaders from both industry and academia to mindshare, benchmark and exchange cutting-edge innovation to manage, strategize and integrate new paradigms to surpass and transcend the quality of all process involved in the drug discovery and development area. During the conference Attana will present how the Attana technology have been applied and can be used in the development of new pharmaceuticals.
For more information, please contact:
Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com
tel: + 46 8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact sales@attana.com.
